DNER and melanoma: These findings are consistent with previous studies whereby BET inhibition restrained the growth of BRAFV600E melanoma cells (Segura et al, 2013; Gallagher et al, 2014; Paoluzzi et al, 2016; Fallahi‐Sichani et al, 2017).